Collectively, these data suggest that theophylline has an anti-fibrotic effect on BLM-induced pulmonary fibrosis by inhibiting the TGF-β/Akt/Smad2/3 pathway. The gene discussed is SMAD2; the disease is pulmonary fibrosis.